O'Shaughnessy Asset Management’s Avidity Biosciences RNAM Stock Holding History

O'Shaughnessy Asset Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,299	Closed	-$526K	–	2803
2025 Q4	$526K	Buy	7,299 +2,476	+51%	+$160K	﹤0.01%	1476
2025 Q3	$210K	Buy	+4,823	New	+$195K	﹤0.01%	1940
2024 Q4	–	Sell	-4,843	Closed	-$226K	–	2279
2024 Q3	$226K	Buy	+4,843	New	+$210K	﹤0.01%	1620

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

O'Shaughnessy Asset Management's RNAM Position: Q1 2026 in Review

O'Shaughnessy Asset Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 7,299 shares — an estimated $526K sold.

O'Shaughnessy Asset Management first reported a position in RNAM in Q3 2024 and held it in 3 quarters. The position peaked at $526K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

O'Shaughnessy Asset Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
O'Shaughnessy Asset Management sold 7,299 Avidity Biosciences shares in Q1 2026, an estimated $526K.
O'Shaughnessy Asset Management first reported a position in Avidity Biosciences in Q3 2024 and held it in 3 quarters.
O'Shaughnessy Asset Management's Avidity Biosciences position peaked at $526K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q1 2026, filed 13 May 2026.